These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 31393173)

  • 61. Transgender women and HIV-related health disparities: falling off the HIV treatment cascade.
    Kalichman SC; Hernandez D; Finneran S; Price D; Driver R
    Sex Health; 2017 Oct; 14(5):469-476. PubMed ID: 28870282
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Prevention of mother-to-child transmission of HIV: antiretroviral strategies.
    Read JS
    Clin Perinatol; 2010 Dec; 37(4):765-76, viii. PubMed ID: 21078449
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Physician contributions to disparities in HIV/AIDS care: the role of provider perceptions regarding adherence.
    Stone VE
    Curr HIV/AIDS Rep; 2005 Nov; 2(4):189-93. PubMed ID: 16343377
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Outcome expectancies toward adherence to antiretroviral therapy for pregnant and postpartum women with HIV.
    Momplaisir FM; Fortune K; Nkwihoreze H; Groves AK; Aaron E; Jemmott JB
    Womens Health (Lond); 2021; 17():17455065211061094. PubMed ID: 34812095
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Raltegravir versus efavirenz in antiretroviral-naive pregnant women living with HIV (NICHD P1081): an open-label, randomised, controlled, phase 4 trial.
    João EC; Morrison RL; Shapiro DE; Chakhtoura N; Gouvèa MIS; de Lourdes B Teixeira M; Fuller TL; Mmbaga BT; Ngocho JS; Njau BN; Violari A; Mathiba R; Essack Z; Pilotto JHS; Moreira LF; Rolon MJ; Cahn P; Prommas S; Cressey TR; Chokephaibulkit K; Werarak P; Laimon L; Hennessy R; Frenkel LM; Anthony P; Best BM; Siberry GK; Mirochnick M
    Lancet HIV; 2020 May; 7(5):e322-e331. PubMed ID: 32386720
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Impact of Dolutegravir-Based Antiretroviral Therapy on Piperaquine Exposure following Dihydroartemisinin-Piperaquine Intermittent Preventive Treatment of Malaria in Pregnant Women Living with HIV.
    Banda CG; Nkosi D; Allen E; Workman L; Madanitsa M; Chirwa M; Kapulula M; Muyaya S; Munharo S; Tarning J; Phiri KS; Mwapasa V; Ter Kuile FO; Maartens G; Barnes KI
    Antimicrob Agents Chemother; 2022 Dec; 66(12):e0058422. PubMed ID: 36374096
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Association between depression and nonadherence to antiretroviral therapy in pregnant women with perinatally acquired HIV.
    Sheth SS; Coleman J; Cannon T; Milio L; Keller J; Anderson J; Argani C
    AIDS Care; 2015; 27(3):350-4. PubMed ID: 25616659
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Trends in Racial and Ethnic Disparities in Antiretroviral Therapy Prescription and Viral Suppression in the United States, 2009-2013.
    Beer L; Bradley H; Mattson CL; Johnson CH; Hoots B; Shouse RL;
    J Acquir Immune Defic Syndr; 2016 Dec; 73(4):446-453. PubMed ID: 27391389
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Understanding Disparities in Antiretroviral Therapy Adherence and Sustained Viral Suppression Among Black, Hispanic/Latina, and White Women in the United States - Medical Monitoring Project, United States, 2015-2019.
    Raiford JL; Yuan X; Carree T; Beer L
    J Acquir Immune Defic Syndr; 2023 Aug; 93(5):413-421. PubMed ID: 37129907
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Implementation and Operational Research: Integration of PMTCT and Antenatal Services Improves Combination Antiretroviral Therapy Uptake for HIV-Positive Pregnant Women in Southern Zambia: A Prototype for Option B+?
    Herlihy JM; Hamomba L; Bonawitz R; Goggin CE; Sambambi K; Mwale J; Musonda V; Musokatwane K; Hopkins KL; Semrau K; Hammond EE; Duncan J; Knapp AB; Thea DM
    J Acquir Immune Defic Syndr; 2015 Dec; 70(4):e123-9. PubMed ID: 26181813
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Prophylactic antiretroviral regimens for prevention of mother-to-child transmission of HIV in resource-limited settings.
    Arrivé E; Dabis F
    Curr Opin HIV AIDS; 2008 Mar; 3(2):161-5. PubMed ID: 19372960
    [TBL] [Abstract][Full Text] [Related]  

  • 72. New Federal guidelines for the use of antiretroviral agents.
    Proj Inf Perspect; 1997 Jul; (22):3-6. PubMed ID: 11364578
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Antiretroviral treatment during pregnancy.
    Keiser O; Gayet-Ageron A; Rudin C; Brinkhof MW; Gremlich E; Wunder D; Drack G; Hirschel B; de Tejada BM; ;
    AIDS; 2008 Nov; 22(17):2323-30. PubMed ID: 18981771
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Hematological parameters of human immunodeficiency virus positive pregnant women on antiretroviral therapy in Aminu Kano Teaching Hospital Kano, North Western Nigeria.
    Abdulqadir I; Ahmed SG; Kuliya AG; Tukur J; Yusuf AA; Musa AU
    J Lab Physicians; 2018; 10(1):60-63. PubMed ID: 29403207
    [TBL] [Abstract][Full Text] [Related]  

  • 75. What's new for antiretroviral treatment in women with HIV.
    Andany N; Walmsley SL
    J Virus Erad; 2016 Apr; 2(2):67-77. PubMed ID: 27482438
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Low Prolactin and High 20-α-Hydroxysteroid Dehydrogenase Levels Contribute to Lower Progesterone Levels in HIV-Infected Pregnant Women Exposed to Protease Inhibitor-Based Combination Antiretroviral Therapy.
    Papp E; Balogun K; Banko N; Mohammadi H; Loutfy M; Yudin MH; Shah R; MacGillivray J; Murphy KE; Walmsley SL; Silverman M; Serghides L
    J Infect Dis; 2016 May; 213(10):1532-40. PubMed ID: 26740274
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Option B plus antiretroviral therapy adherence and associated factors among HIV positive pregnant women in Southern Ethiopia.
    Tesfaye DJ; Hibistu DT; Abebo TA; Asfaw FT; Lukas K; Laelago T; Turuse EA; Kebede HG; Altaye AA; Bekele FB
    BMC Pregnancy Childbirth; 2019 Feb; 19(1):82. PubMed ID: 30819147
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Low rates of mother-to-child transmission of HIV following effective pregnancy interventions in the United Kingdom and Ireland, 2000-2006.
    Townsend CL; Cortina-Borja M; Peckham CS; de Ruiter A; Lyall H; Tookey PA
    AIDS; 2008 May; 22(8):973-81. PubMed ID: 18453857
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Differential diffusion of HIV technologies by gender: the case of highly active antiretroviral therapy.
    Eisenman D; Bogart LM; Bird CE; Collins RL; Golinelli D; Fremont A; Beckman R; Cunningham W
    AIDS Patient Care STDS; 2007 Jun; 21(6):390-9. PubMed ID: 17594248
    [TBL] [Abstract][Full Text] [Related]  

  • 80.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.